Clinical Trial Update: Follow-up of Migraine Patients on Eptinezumab

View source ↗

Summary

Follow-up update from a completed study evaluating eptinezumab in migraine patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• VYEPTI (eptinezumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Migraine | Status: COMPLETED